title: Re: AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.
authors.affiliation: Department of Urology, Skåne University Hospital Malmö, Malmö, Sweden; Department of Clinical Sciences Malmö, Division of Urological Cancers, Lund University, Lund, Sweden.
authors.forename: Aseem Undvall
authors.initials: AU
authors.lastname: Anand
authors.affiliation: Department of Urology, Skåne University Hospital Malmö, Malmö, Sweden; Department of Clinical Sciences Malmö, Division of Urological Cancers, Lund University, Lund, Sweden. Electronic address: anders.bjartell@med.lu.se.
authors.forename: Anders
authors.initials: A
authors.lastname: Bjartell
mesh_terms: D000737:Androstenols / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D006801:Humans; D008297:Male; D010669:Phenylthiohydantoin / Q000031:analogs & derivatives*; D011471:Prostatic Neoplasms / Q000235:genetics*; D012334:RNA, Neoplasm / Q000032:analysis*; D011944:Receptors, Androgen / Q000235:genetics*
chemical_list: D000737:Androstenols; D012334:RNA, Neoplasm; D011944:Receptors, Androgen; D010669:Phenylthiohydantoin